Table 1.

Examples of Areas for Potential Improvement Identified by Stewards and Interventions Considered or Developed

Area for Improvement	Intervention
High utilization of anti-methicillin-resistant Staphylococcus aureus and antipseudomonal agents at Choice	Introduction of serial procalcitonin testing for patients with suspected sepsis or lower respiratory tract infection
	Timeout program to encourage deescalation
High fluoroquinolone utilization	Creation and evaluation of treatment pathways and order sets that deemphasize fluoroquinolone use
	Creation of urinary antibiogram to assist in selection of nonfluoroquinolone options
Antipseudomonal agent utilization in SSTI	Pilot program in which providers who use antipseudomonal agents for SSTI are emailed reminders as to the proper indications for their use in SSTI
Excessive duration of therapy	Development of syndrome-specific treatment pathways

Abbreviation: SSTI, skin/soft tissue infection.